Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Allergy Therapeutics PLC?

Accepted Answer

Según el último estado financiero (Form-10K), Allergy Therapeutics PLC tiene un total de activos de $64, una ganancia neta loss de $-40

Question 2

¿Cuáles son los ratios financieros clave para AGYTF?

Accepted Answer

El ratio corriente de Allergy Therapeutics PLC es 1.04, el margen neto es -72.72, las ventas por acción son $0.01.

Question 3

¿Cómo se desglosan los ingresos de Allergy Therapeutics PLC por segmento o geografía?

Accepted Answer

Allergy Therapeutics PLC largest revenue segment is Allergy-related Medicines, at a revenue of 55,199,000 in the most earnings release.For geography, Germany is the primary market for Allergy Therapeutics PLC, at a revenue of 27,047,510.

Question 4

¿Es rentable Allergy Therapeutics PLC?

Accepted Answer

no, según los últimos estados financieros, Allergy Therapeutics PLC tiene una ganancia neta loss de $-40

Question 5

¿Tiene Allergy Therapeutics PLC alguna deuda?

Accepted Answer

yes, Allergy Therapeutics PLC tiene una deuda de 61

Question 6

¿Cuántas acciones en circulación tiene Allergy Therapeutics PLC?

Accepted Answer

Allergy Therapeutics PLC tiene un total de acciones en circulación de 4,766.43

Breakdown	TTM	06/30/2024	06/30/2023	06/30/2022	06/30/2021	06/30/2020
Revenue	55	55	59	72	84	78
Revenue Growth (YoY)	4%	-7%	-18%	-14%	8%	7%
Cost of Revenue	25	25	26	23	22	20
Gross Profit	30	29	33	49	62	58
Selling, General & Admin	40	42	48	46	45	44
Research & Development	19	22	20	15	12	9
Operating Expenses	58	63	68	61	58	49
Other Non Operating Income (Expenses)	--	0	0	0	0	0
Pretax Income	-35	-39	-41	-12	3	8
Income Tax Expense	0	1	1	1	0	1
Net Income	-35	-40	-43	-13	2	7
Net Income Growth	-30%	-7%	231%	-750%	-71%	133%
Shares Outstanding (Diluted)	4,766.44	3,743.33	1,456.28	1,396.83	1,469.97	673.49
Shares Change (YoY)	75%	157%	4%	-5%	118%	1%
EPS (Diluted)	0	-0.01	-0.02	0	0	0.01
EPS Growth	-74%	-64%	199%	-595%	-81%	102%
Free Cash Flow	-32	-35	-33	-17	5	9
Free Cash Flow Per Share	0	0	-0.02	-0.01	0	0.01
Gross Margin	54.54%	52.72%	55.93%	68.05%	73.8%	74.35%
Operating Margin	-50.9%	-61.81%	-57.62%	-16.66%	4.76%	10.25%
Profit Margin	-63.63%	-72.72%	-72.88%	-18.05%	2.38%	8.97%
Free Cash Flow Margin	-58.18%	-63.63%	-55.93%	-23.61%	5.95%	11.53%
EBITDA	-24	-30	-30	-8	8	11
EBITDA Margin	-43.63%	-54.54%	-50.84%	-11.11%	9.52%	14.1%
D&A For EBITDA	4	4	4	4	4	3
EBIT	-28	-34	-34	-12	4	8
EBIT Margin	-50.9%	-61.81%	-57.62%	-16.66%	4.76%	10.25%
Effective Tax Rate	0%	-2.56%	-2.43%	-8.33%	0%	12.5%

Allergy Therapeutics PLC (AGYTF) Price

AGYTF Stock Price Chart

AGYTF Income

Follow-Up Questions